Our meta-analysis reveals that AXIN2 (Figure 1E) is consistently expressed at a higher level in tumor relative to normal tissue, and so is LGR5 (Figure 1H), indicating as expected increased Wnt/β-catenin signaling activity [35] and increased stem cell identity of tumor tissue [42]. This evidence concerns the gene AXIN2 and neoplasm.